|
Volumn 99, Issue 3, 2005, Pages 1235-1238
|
Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN;
ENDOTHELIN A RECEPTOR;
ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR;
NITRIC OXIDE;
PROSTACYCLIN;
VASODILATOR AGENT;
ATHEROSCLEROSIS;
BLOOD FLOW VELOCITY;
CORONARY ARTERY;
FLOW;
HUMAN;
HYPEREMIA;
ISCHEMIA;
PRIORITY JOURNAL;
RADIAL ARTERY;
REVIEW;
SHEAR STRESS;
SYMPATHETIC TONE;
VASCULAR ENDOTHELIUM;
VASODILATATION;
ANIMALS;
ARTERIES;
BLOOD FLOW VELOCITY;
BLOOD PRESSURE;
CLINICAL TRIALS;
ENDOTHELIUM, VASCULAR;
EVIDENCE-BASED MEDICINE;
HUMANS;
MECHANOTRANSDUCTION, CELLULAR;
NITRIC OXIDE;
VASODILATION;
|
EID: 24044500607
PISSN: 87507587
EISSN: None
Source Type: Journal
DOI: 10.1152/japplphysiol.00607.2005 Document Type: Review |
Times cited : (52)
|
References (0)
|